|
US5840565A
(en)
*
|
1995-08-22 |
1998-11-24 |
The Regents Of The University Of California |
Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
|
|
US6855519B2
(en)
*
|
1995-08-22 |
2005-02-15 |
The Regents Of The University Of California |
Methods for enhancing the production of interferon in cell culture
|
|
US6740519B1
(en)
|
1997-11-03 |
2004-05-25 |
Mount Sinai School Of Medicine |
Immortalized, homozygous stat1-deficient mammalian cell lines and their uses
|
|
NZ509055A
(en)
|
1998-06-12 |
2004-02-27 |
Sinai School Medicine |
Methods and interferon deficient substrates for the propagation of viruses
|
|
US6762038B1
(en)
*
|
1998-09-09 |
2004-07-13 |
The Cleveland Clinic Foundation |
Mutant cell lines and methods for producing enhanced levels of recombinant proteins
|
|
CN1399681A
(zh)
*
|
1999-06-15 |
2003-02-26 |
基因特罗生物治疗公司 |
在细胞培养物中增强细胞因子产生的方法
|
|
EP1067179A1
(en)
*
|
1999-07-09 |
2001-01-10 |
Pierre Fabre Medicament |
Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
|
|
US20010031859A1
(en)
*
|
1999-09-08 |
2001-10-18 |
Lau Allan S. |
High level cytokine production with enhanced cell viability
|
|
WO2001018185A1
(en)
*
|
1999-09-08 |
2001-03-15 |
Genetrol Biotherapeutics, Inc. |
High level cytokine production with enhanced cell viability
|
|
WO2001077394A1
(en)
|
2000-04-10 |
2001-10-18 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
|
IL136232A0
(en)
*
|
2000-05-18 |
2001-05-20 |
Bar Ilan University Res Author |
Measurements of enzymatic activity in a single, individual cell in population
|
|
AU2001278139A1
(en)
*
|
2000-08-04 |
2002-02-18 |
Chiron Corporation |
Enhanced replication of hcv rna
|
|
US20020150541A1
(en)
*
|
2000-09-12 |
2002-10-17 |
Gene Trol Biotherapeutics, Inc. |
Compositions comprising mixtures of therapeutic proteins and methods of producing the same
|
|
WO2002022786A1
(en)
|
2000-09-14 |
2002-03-21 |
Genetrol Biotherapeutics, Inc. |
Method and cell composition for screening compounds for anti-inflammatory activity
|
|
AU2002251714A1
(en)
*
|
2000-12-19 |
2002-08-19 |
Genetrol Biotherapeutics, Inc. |
Cells with enhanced pkr expression for increasing cytokine production
|
|
DE10104094C1
(de)
*
|
2001-01-31 |
2002-07-25 |
Angelika Vallbracht-Flehmig |
Verfahren zur Erhöhung der Virusvermehrung und Virusausbeute in Zellkulturen, durch Blockade der RNaseL-Aktivierung
|
|
JP4192097B2
(ja)
*
|
2001-10-25 |
2008-12-03 |
バル−イラン ユニバーシティ |
相互作用型透明個別細胞バイオチッププロセッサー
|
|
IL154677A0
(en)
|
2003-02-27 |
2003-09-17 |
Univ Bar Ilan |
A method and apparatus for manipulating an individual cell
|
|
US9200245B2
(en)
|
2003-06-26 |
2015-12-01 |
Seng Enterprises Ltd. |
Multiwell plate
|
|
US7888110B2
(en)
|
2003-06-26 |
2011-02-15 |
Seng Enterprises Ltd. |
Pico liter well holding device and method of making the same
|
|
US8597597B2
(en)
|
2003-06-26 |
2013-12-03 |
Seng Enterprises Ltd. |
Picoliter well holding device and method of making the same
|
|
US20060240548A1
(en)
*
|
2003-06-26 |
2006-10-26 |
Mordechai Deutsch |
Materials for constructing cell-chips, cell-chip covers, cell-chips coats, processed cell-chips and uses thereof
|
|
US7982751B2
(en)
*
|
2003-07-11 |
2011-07-19 |
The University Of North Carolina |
Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
|
|
RU2390351C2
(ru)
*
|
2003-08-11 |
2010-05-27 |
Дзе Ресерч Фаундейшн Фо Макробайал Дизизес Оф Осака Юниверсити |
Вакцина против вируса гриппа для введения через слизистую и способ предотвращения гриппа
|
|
US20050064524A1
(en)
*
|
2003-08-11 |
2005-03-24 |
Mordechai Deutsch |
Population of cells utilizable for substance detection and methods and devices using same
|
|
JP2007529199A
(ja)
*
|
2003-10-23 |
2007-10-25 |
イルミジェン バイオサイエンシーズ， インコーポレイテッド |
ウイルス感染に対する抵抗性に関連する遺伝子である、ｏａｓ１における変異の検出
|
|
US20050191649A1
(en)
*
|
2003-10-23 |
2005-09-01 |
Illumigen Biosciences, Inc. |
Detection of mutations in a gene associated with resistance to viral infection, OAS1
|
|
US8778880B2
(en)
|
2004-02-02 |
2014-07-15 |
Ambrx, Inc. |
Human growth hormone modified at position 35
|
|
CA2554927A1
(en)
*
|
2004-02-03 |
2005-08-18 |
Chemagis Ltd. |
Stable amorphous forms of montelukast sodium
|
|
DE602005015332D1
(de)
*
|
2004-02-23 |
2009-08-20 |
Crucell Holland Bv |
Verfahren zur Reinigung von Viren
|
|
EP3332803B1
(en)
|
2004-06-01 |
2021-09-08 |
Icahn School of Medicine at Mount Sinai |
Genetically engineered swine influenza virus and uses thereof
|
|
EP1763665A1
(en)
*
|
2004-07-07 |
2007-03-21 |
Seng Enterprises Limited |
Method and device for identifying an image of a well in an image of a well-bearing component
|
|
US7403647B2
(en)
*
|
2004-09-13 |
2008-07-22 |
Seng Enterprises Ltd. |
Method for identifying an image of a well in an image of a well-bearing component
|
|
AU2009212311B8
(en)
|
2004-07-21 |
2013-05-30 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
|
WO2006021959A2
(en)
*
|
2004-08-25 |
2006-03-02 |
Seng Enterprises Ltd. |
Method and device for isolating cells
|
|
US20060051369A1
(en)
*
|
2004-08-27 |
2006-03-09 |
Taylor Deborah R |
ADAR1 antiviral pathway
|
|
US20080107683A1
(en)
*
|
2004-11-30 |
2008-05-08 |
David Hone |
Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
|
|
ES2352344T3
(es)
|
2005-01-25 |
2011-02-17 |
Seng Enterprises Limited |
Dispositivo de microfluido para estudio de células.
|
|
US8137676B2
(en)
|
2005-02-15 |
2012-03-20 |
Mount Sinai School Of Medicine |
Genetically engineered equine influenza virus and uses thereof
|
|
EP1869171B2
(en)
*
|
2005-04-11 |
2015-10-14 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
UA95446C2
(ru)
*
|
2005-05-04 |
2011-08-10 |
Іллюміджен Байосайєнсіз, Інк. |
Мутаци в генах oas1
|
|
DE102005034043B4
(de)
*
|
2005-07-18 |
2019-12-12 |
Südzucker Aktiengesellschaft Mannheim/Ochsenfurt |
Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
|
|
US20070111309A1
(en)
*
|
2005-10-04 |
2007-05-17 |
Daelli Marcelo G |
Vero cell line adapted to grow in suspension
|
|
US20070141555A1
(en)
*
|
2005-10-11 |
2007-06-21 |
Mordechai Deutsch |
Current damper for the study of cells
|
|
US8288120B2
(en)
|
2005-11-03 |
2012-10-16 |
Seng Enterprises Ltd. |
Method for studying floating, living cells
|
|
US20070196333A1
(en)
*
|
2006-02-23 |
2007-08-23 |
Fu-Yung Lin |
Composition comprising mixtures of IFN-alpha subtypes
|
|
US20060223999A1
(en)
*
|
2006-05-10 |
2006-10-05 |
Chemagis Ltd. |
Process for preparing montelukast and precursors thereof
|
|
AU2008247815B2
(en)
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
|
US9145540B1
(en)
|
2007-11-15 |
2015-09-29 |
Seng Enterprises Ltd. |
Device for the study of living cells
|
|
WO2009081409A2
(en)
|
2007-12-26 |
2009-07-02 |
Seng Enterprises Ltd. |
Device for the study of living cells
|
|
EP2133358A1
(en)
*
|
2008-06-10 |
2009-12-16 |
Universitätsklinikum Freiburg |
Rift valley fever virus-like particles and their use for immunization and as test system
|
|
JP5689796B2
(ja)
|
2008-08-01 |
2015-03-25 |
ガマ ワクチンズ ピーティワイ リミテッド |
インフルエンザワクチン
|
|
JP5686741B2
(ja)
|
2008-12-16 |
2015-03-18 |
バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ |
インフルエンザワクチンの生成
|
|
WO2011130119A2
(en)
|
2010-04-14 |
2011-10-20 |
Millipore Corporation |
Methods of producing high titer, high purity virus stocks and methods of use thereof
|
|
US20140079732A1
(en)
|
2011-01-27 |
2014-03-20 |
Gamma Vaccines Pty Limited |
Combination vaccines
|
|
US20150161359A1
(en)
*
|
2012-06-04 |
2015-06-11 |
Novartis Ag |
Methods for safety testing
|
|
CN108588027A
(zh)
|
2013-02-05 |
2018-09-28 |
乔治亚大学研究基金公司 |
用于病毒生产的细胞系和使用方法
|
|
WO2016137929A1
(en)
|
2015-02-26 |
2016-09-01 |
Boehringer Ingelheim Vetmedica Gmbh |
Bivalent swine influenza virus vaccine
|
|
US11560418B2
(en)
*
|
2015-10-20 |
2023-01-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for modified factor IX fusion proteins
|
|
KR102651055B1
(ko)
|
2016-03-24 |
2024-03-26 |
삼성디스플레이 주식회사 |
광학 필름 및 디스플레이 장치
|